Search - tctmd.com

Displaying 161 - 180 of 244

Sort: Relevancy | Date

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

L.A. McKeown

January 15, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Todd Neale

November 13, 2020

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Todd Neale

November 02, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

More HF Readmissions Among Black People From Deprived Neighborhoods

News Conference News HFSA 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Shelley Wood

May 11, 2020

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

Advertisement

Women Treated for Acute HF Report Worse QoL Than Men

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

FDA Approves Vericiguat for High-risk Patients With HF

Hospitalization for HF After Acute MI More Common in Women Than Men

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

More HF Readmissions Among Black People From Deprived Neighborhoods

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content